Abstract
No public abstract is available from the verified source records.
Neeraj Kumar, Manish Kumar Gupta, Dev Brat Mishra
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
openalex
Confidence 95%
datacite
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Mass-spectrometric exploration of proteome structure and function
10.1038/nature19949 · 2016
Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 2: a discussion of chemical and biological data
10.1016/j.drudis.2020.11.037 · 2021
Cancer drug response profile scan (CDRscan): a deep learning model that predicts drug effectiveness from cancer genomic signature
10.1038/s41598-018-27214-6 · 2018
Deep learning–based multi-omics integration for cancer survival prediction
2018
Leveraging big data to transform target selection and drug discovery
10.1002/cpt.318 · 2016
Has drug design augmented by artificial intelligence become a reality?
10.1016/j.tips.2019.09.004 · 2019
The rise of deep learning in drug discovery
10.1016/j.drudis.2018.01.039 · 2018
FDA-approved drug labeling for the study of drug-induced liver injury
10.1016/j.drudis.2011.05.007 · 2011
Applications of artificial intelligence in drug development using real-world data
10.1016/j.drudis.2020.12.013 · 2021
Confidence 0%
Artificial intelligence in drug discovery: Applications and techniques
10.1093/bib/bbab430 · 2022
The next era: deep learning in pharmaceutical research
10.1007/s11095-016-2029-7 · 2016
Exploiting machine learning for end-to-end drug discovery and development
10.1038/s41563-019-0338-z · 2019
Synthesis of small molecules targeting multiple DNA structures using click chemistry
10.1002/cmdc.201200060 · 2012
Tox21 challenge to build predictive models of nuclear receptor and stress response pathways as mediated by exposure to environmental chemicals and drugs
10.3389/fenvs.2015.00085 · 2016
Bidirectional RNN for medical event detection in electronic health records
2016
DeepSite: protein-binding site predictor using 3D-convolutional neural networks
10.1093/bioinformatics/btx350 · 2018
Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines
10.1016/j.drudis.2013.11.005 · 2014
Highly accurate protein structure prediction with AlphaFold
10.1038/s41586-021-03819-2 · 2021
druGAN: an advanced generative adversarial autoencoder model for de novo generation of new molecules with desired molecular properties in silico
10.1021/acs.molpharmaceut.7b00346 · 2017
PubChem substance and compound databases
10.1093/nar/gkaa971 · 2019
Machine learning applications in cancer prognosis and prediction
10.1016/j.csbj.2014.11.005 · 2015
The SIDER database of drugs and side effects
10.1093/nar/gkv1075 · 2016
Integrating multi-omics data for drug response prediction using deep learning
2020
Deep learning-based prediction of drug response in cancer
10.1093/bib/bbz171 · 2021
Assessment of an in silico mechanistic model for proarrhythmia risk prediction under the CiPA initiative
10.1002/cpt.1184 · 2019
VigiBase, the WHO global ICSR database system: basic facts
10.1177/009286150804200501 · 2008
Lost in translation: animal models and clinical trials in cancer treatment
2014
DeepTox: toxicity prediction using deep learning
2016
ChEMBL: towards direct deposition of bioassay data
10.1093/nar/gky1075 · 2019
Deep learning for healthcare: review, opportunities and challenges
10.1093/bib/bbx044 · 2018
GraphDTA: predicting drug–target binding affinity with graph neural networks
10.1093/bioinformatics/btaa921 · 2021
Molecular de novo design through deep reinforcement learning
10.1186/s13321-017-0235-x · 2017
DeepDTA: deep drug–target binding affinity prediction
10.1093/bioinformatics/bty593 · 2018
How to improve R&D productivity: the pharmaceutical industry’s grand challenge
10.1038/nrd3078 · 2010
Better prediction of the local concentration–effect relationship: The role of physiologically based pharmacokinetics and quantitative systems pharmacology and toxicology in the evolution of model-informed drug discovery and development
10.1016/j.drudis.2019.05.016 · 2019
Prediction of cardiovascular risk factors from retinal fundus photographs via deep learning
10.1038/s41551-018-0195-0 · 2018
Machine learning approaches and their applications in drug discovery and design
10.1111/cbdd.14057 · 2022
Drug repurposing: progress, challenges and recommendations
10.1038/nrd.2018.168 · 2019
Machine learning in medicine
10.1056/nejmra1814259 · 2019
DeepChem: a deep learning platform for drug discovery
2017
Modeling polypharmacy side effects with graph convolutional networks
10.1093/bioinformatics/bty294 · doi-reference
Artificial intelligence in drug design
10.1007/s11427-018-9342-2 · doi-reference
Deep learning enables rapid identification of potent DDR1 kinase inhibitors
10.1038/s41587-019-0224-x · doi-reference
Artificial intelligence for drug discovery, biomarker development, and generation of novel chemistry
10.1021/acs.molpharmaceut.8b00930 · doi-reference
Data mining reveals a network of early-response genes as a consensus signature of drug-induced in vitro and in vivo toxicity
10.1038/tpj.2013.39 · doi-reference
deepDR: A network-based deep learning approach to in silico drug repositioning
10.1093/bioinformatics/btz418 · doi-reference
Artificial intelligence in healthcare
10.1038/s41551-018-0305-z · doi-reference
Analyzing learned molecular representations for property prediction
10.1021/acs.jcim.9b00237 · doi-reference
Implementation of deep learning in drug design
10.1002/mef2.18 · doi-reference
Deep learning for toxicity prediction in drug development
10.1021/acs.jcim.5b00238 · doi-reference
The CompTox chemistry dashboard: a community data resource for environmental chemistry
10.1186/s13321-017-0247-6 · doi-reference
An analysis of the attrition of drug candidates from four major pharmaceutical companies
10.1038/nrd4609 · doi-reference
Drug–drug interaction through molecular structure similarity analysis
10.1136/amiajnl-2012-000935 · doi-reference
Applications of machine learning in drug discovery and development
10.1038/s41573-019-0024-5 · doi-reference
Best practices for QSAR model development, validation, and exploitation
10.1002/minf.201000061 · doi-reference
High-performance medicine: the convergence of human and artificial intelligence
10.1038/s41591-018-0300-7 · doi-reference
Data-driven prediction of drug effects and interactions
10.1126/scitranslmed.3003377 · doi-reference
Recent advances of deep learning in bioinformatics and computational biology
10.3389/fgene.2019.00214 · doi-reference
Artificial intelligence and machine learning in clinical development: a translational perspective
10.1038/s41746-019-0148-3 · doi-reference
Utilizing social media data for pharmacovigilance: a review
10.1016/j.jbi.2015.02.004 · doi-reference
ToxCast chemical landscape: paving the road to 21st century toxicology
10.1021/acs.chemrestox.6b00135 · doi-reference
Pharmacogenomics in the clinic
10.1038/nature15817 · doi-reference
Machine learning in medicine
10.1056/nejmra1814259 · doi-reference
Drug repurposing: progress, challenges and recommendations
10.1038/nrd.2018.168 · doi-reference
Machine learning approaches and their applications in drug discovery and design
10.1111/cbdd.14057 · doi-reference
Prediction of cardiovascular risk factors from retinal fundus photographs via deep learning
10.1038/s41551-018-0195-0 · doi-reference
Better prediction of the local concentration–effect relationship: The role of physiologically based pharmacokinetics and quantitative systems pharmacology and toxicology in the evolution of model-informed drug discovery and development
10.1016/j.drudis.2019.05.016 · doi-reference
How to improve R&D productivity: the pharmaceutical industry’s grand challenge
10.1038/nrd3078 · doi-reference
DeepDTA: deep drug–target binding affinity prediction
10.1093/bioinformatics/bty593 · doi-reference
Molecular de novo design through deep reinforcement learning
10.1186/s13321-017-0235-x · doi-reference
GraphDTA: predicting drug–target binding affinity with graph neural networks
10.1093/bioinformatics/btaa921 · doi-reference
Deep learning for healthcare: review, opportunities and challenges
10.1093/bib/bbx044 · doi-reference
ChEMBL: towards direct deposition of bioassay data
10.1093/nar/gky1075 · doi-reference
VigiBase, the WHO global ICSR database system: basic facts
10.1177/009286150804200501 · doi-reference
Assessment of an in silico mechanistic model for proarrhythmia risk prediction under the CiPA initiative
10.1002/cpt.1184 · doi-reference
Deep learning-based prediction of drug response in cancer
10.1093/bib/bbz171 · doi-reference
The SIDER database of drugs and side effects
10.1093/nar/gkv1075 · doi-reference
Machine learning applications in cancer prognosis and prediction
10.1016/j.csbj.2014.11.005 · doi-reference
PubChem substance and compound databases
10.1093/nar/gkaa971 · doi-reference
druGAN: an advanced generative adversarial autoencoder model for de novo generation of new molecules with desired molecular properties in silico
10.1021/acs.molpharmaceut.7b00346 · doi-reference